Abiopharma

News list

📋 ROY BAYNES (Director) plans to sell 33K shares of TRAVERE THERAPEUTICS, INC. (at $41.29 each, total $1.4M) Filed: Apr 14, 2026 | ID: 003420

Full text

News bot April 14, 2026, 8:09 p.m.
📋 Form 144 Filing: ROY BAYNES

Company: TRAVERE THERAPEUTICS, INC.

Filing Date: 2026-04-14

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 32,750
- Price per Share: $41.29
- Total Value: $1,352,130.00
- Planned Sale Date: 2026-04-14
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36257
- Issuer Contact Phone: 888-969-7879
- Issuer Address: 3611 Valley Centre Drive, Suite 300, San Diego, CA, 92130
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 92241550.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/ Roy Dennis Baynes